These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Discovery of novel diarylketoxime derivatives as selective and orally active melanin-concentrating hormone 1 receptor antagonists. Suzuki T; Kameda M; Ando M; Miyazoe H; Sekino E; Ito S; Masutani K; Kamijo K; Takezawa A; Moriya M; Ito M; Ito J; Nakase K; Matsushita H; Ishihara A; Takenaga N; Tokita S; Kanatani A; Sato N; Fukami T Bioorg Med Chem Lett; 2009 Sep; 19(18):5339-45. PubMed ID: 19683441 [TBL] [Abstract][Full Text] [Related]
11. Effects of a selective melanin-concentrating hormone 1 receptor antagonist on food intake and energy homeostasis in diet-induced obese mice. Kowalski TJ; Spar BD; Weig B; Farley C; Cook J; Ghibaudi L; Fried S; O'Neill K; Del Vecchio RA; McBriar M; Guzik H; Clader J; Hawes BE; Hwa J Eur J Pharmacol; 2006 Mar; 535(1-3):182-91. PubMed ID: 16540104 [TBL] [Abstract][Full Text] [Related]
13. Melanin-concentrating hormone 1-receptor antagonist suppresses body weight gain correlated with high receptor occupancy levels in diet-induced obesity mice. Ito M; Ishihara A; Gomori A; Egashira S; Matsushita H; Mashiko S; Ito J; Ito M; Nakase K; Haga Y; Iwaasa H; Suzuki T; Ohtake N; Moriya M; Sato N; MacNeil DJ; Takenaga N; Tokita S; Kanatani A Eur J Pharmacol; 2009 Dec; 624(1-3):77-83. PubMed ID: 19836369 [TBL] [Abstract][Full Text] [Related]
14. Melanin-concentrating hormone receptor 1 antagonists: a new perspective for the pharmacologic treatment of obesity. Rivera G; Bocanegra-García V; Galiano S; Cirauqui N; Ceras J; Pérez S; Aldana I; Monge A Curr Med Chem; 2008; 15(10):1025-43. PubMed ID: 18393860 [TBL] [Abstract][Full Text] [Related]
15. Solid-phase synthesis and structure-activity relationships of novel biarylethers as melanin-concentrating hormone receptor-1 antagonists. Ma V; Bannon AW; Baumgartner J; Hale C; Hsieh F; Hulme C; Rorrer K; Salon J; van Staden C; Tempest P Bioorg Med Chem Lett; 2006 Oct; 16(19):5066-72. PubMed ID: 16887348 [TBL] [Abstract][Full Text] [Related]
16. Building a MCHR1 homology model provides insight into the receptor-antagonist contacts that are important for the development of new anti-obesity agents. Cirauqui N; Schrey AK; Galiano S; Ceras J; Pérez-Silanes S; Aldana I; Monge A; Kühne R Bioorg Med Chem; 2010 Nov; 18(21):7365-79. PubMed ID: 20932767 [TBL] [Abstract][Full Text] [Related]
17. Recent patents on novel MCH1 receptor antagonists as potential anti-obesity drugs. Szalai KK; Beke G; Éles J; Kitka T; Kovács P; Nagy J; Farkas S; Boros A Recent Pat CNS Drug Discov; 2014; 9(2):122-40. PubMed ID: 24924101 [TBL] [Abstract][Full Text] [Related]